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Abstract
Background: Depression and anxiety are psychiatric disorders that are related to tobacco use and associated with dependence, the process of cessation, lapses 
and relapses after quitting smoking. Objective: To analyze the association of nicotine dependence with the level of anxiety and depression in patients who 
are in the process of smoking cessation. Methods: Cross-sectional study conducted with patients who sought the smoking cessation program in Cuiabá/MT. 
All the smokers enrolled from May to August 2012, participated in this study. Four instruments were applied: Socio-demographic Questionnaire, Fagerström 
test, Beck Anxiety Inventory and Beck Depression Inventory. Following bivariate analysis, using the crude prevalence ratio, with level of significance lower 
than 5% (p < 0.05), having as variable outcome the nicotine dependence ≥ 5 (Fagerström). The associations with p < 0.20 were selected for robust Multiple 
Poisson Regression (RPa). Results: Associations of Fagerström ≥ 5 with the male sex (RP = 1.15 CI 95% 1.03-1.28); number of cigarettes/day (RP = 1,33; CI 
95% 1.19-1.48); and moderate/severe level of depression (RP = 1.15; CI 95% 1.04-1.28) were found. In the final model (RPa), the following variables remained 
associated: male gender (RPa 1.12; CI 95% 1.01-1.24), number of cigarettes/day (RPa 1.28; CI 95% 1.15-1.43) and high level of depression (RPa 1.12; CI 95% 
1.01-1.23). Discussion: High level of nicotine dependence was associated significantly with the level of depression, emphasizing the association between 
smoking and psychiatric comorbidities.
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Resumo
Contexto: Depressão e ansiedade são patologias psiquiátricas que estão relacionadas ao tabagismo e associadas com a dependência, o processo de cessação, 
lapsos e recaídas após parar de fumar. Objetivo: Analisar a associação da dependência da nicotina com o nível de ansiedade e depressão de pacientes em 
cessação do tabagismo. Métodos: Estudo transversal realizado com pacientes dos programas de cessação do tabagismo de Cuiabá/MT. Todos os fumantes 
matriculados, durante o período de maio a agosto de 2012, participaram deste estudo. Foram aplicados quatro instrumentos: Questionário sociodemográfico, 
teste de Fagerström, Inventário de Ansiedade de Beck e Inventário de Depressão de Beck. Feita análise bivariada, razão de prevalência bruta, com nível de 
significância de 5% (p < 0,05), tendo como variável desfecho a dependência nicotínica ≥ a 5 (Fagerström). As associações com p < 0,20 foram selecionadas 
para a Regressão de Poisson Múltipla robusta (RPa). Resultados: Foram encontradas associações do Fagerström ≥ 5 com sexo masculino (RP = 1,15 IC 95% 
1,03-1,28); quantidade de cigarros fumados/dia (RP = 1,33; IC 95% 1,19-1,48); e nível de depressão moderado/grave (RP = 1,15; IC 95% 1,04-1,28). No modelo 
final (RPa), permaneceram associadas as variáveis: sexo masculino (RPa 1,12; IC 95% 1,01-1,24), número de cigarros/dia (RPa 1,28; IC 95% 1,15-1,43) e alto 
nível de depressão (RPa 1,12; IC 95% 1,01-1,23). Conclusão: Alta dependência de nicotina foi associada significativamente ao nível de depressão, evidenciando 
a associação entre tabagismo e comorbidades psiquiátricas.
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Introduction
Smoking, besides being a known risk factor for several diseases, is 
itself a disease. Mostly, the beginning of this disease is explained by 
nicotine dependence that most of the smokers have, being related to 
the genetics of the individual, environmental factors and the number 
of cigarettes smoked/time spent smoking (smoking burden)1,2. The 
clinical expression of this dependence occurs when the smoker quits 
smoking and presents a large variety of characteristic symptoms 
(craving, tremors, sweating, agitation, lack of concentration etc.), 
emphasizing the intense desire to smoke again, which most of the 
time becomes compulsive and uncontrollable (craving)2,3.
The evaluation of the nicotine dependence becomes indispens-
able for the smokers in the cessation process, because among the 
factors that make this process even more difficult, the degree of 
dependence is determinant, both in the decision-making to quit 
the cigarette and to continue without it2,4,5. The Fagerströn Test is 
the most known evaluation tool and when the smoker reaches five 
or more points in this test he/she is classified as being on a medium, 
high or very high dependence level. The smoker being considered as 
a heavy smoker has the biggest chances of failure3. Moreover, there is 
a need for medication due to the degree of physical dependence on 
nicotine, which demands drug intervention and/or the behavioral 
cognitive therapy (BCT), in order to ensure less individual suffer-
ing and improve the chances of success. The remission rate without 
intervention is very high in this kind of smoker2,3.
The relation between depression and anxiety with smoking has 
been reported in literature, with these variables associated both with 
the addiction itself, regarding the limiting factors in the cessation 
process, as well as facilitators of lapses and relapses after quitting 
smoking with or without pharmacological treatment or psychological 
support with the TCC6.
Concerning depression, there are several hypotheses about the 
nature of this association. Smoking could act as “self-medication” of 
feelings of sadness or negative mood. There is evidence that the use 
of nicotine interferes with the neurochemical systems and fosters 
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the neural circuits of the central nervous system, such as reinforce-
ment mechanisms associated with mood regulator7. There is also the 
hypothesis that, more than a unidirectional relation, smoking and 
depression can influence each other reciprocally. Depressed smokers 
can smoke to alleviate their negative feelings and, therefore, smok-
ing for these individuals becomes reinforcing. Another explanatory 
theory that has been gaining more adepts is that a series of common 
variables (such as genetic and psychosocial factors), contribute for 
the expression of both (smoking and depression)8. In the smokers 
with depressive symptoms in the cessation process, it is known that 
the probability of smoking abandonment is reduced, with higher risk 
of relapse during the withdrawal period, compared to the smoker 
without the same history2. Furthermore, this smoker runs the risk 
of developing more significant depressive episodes, often requir-
ing specific treatment or even specialized help in the treatment of 
psychiatric diseases9.
In relation to anxiety, it is known that anxious people are more 
likely to start smoking and also to become tobacco dependent10. To 
some extent, this is explained by the effect of nicotine in the brain 
circuits when anxiety is reduced, euphoria is produced and other 
sensations perceived as pleasant by the smoker11. Mood changes are 
noticed when the smoker is in the withdrawal process, because that 
apparent balance is lost, turning him into an agitated, impatient and 
lacking the necessary concentration for his daily activities12. Thus, 
smokers diagnosed with anxiety tend to have lower probabilities of 
withdrawal in the long term, compared to those without diagnoses 
of anxiety, who need to be monitored throughout the cessation 
process13.
This study has been designed taking into account the knowl-
edge about the relation between smoking and psychological and/
or  psychiatric disorders in smokers in the process of cessation. The 
main aim is to analyze the relation between the nicotine dependence 
level and the levels of depression and anxiety, aiming to support and 
optimize the action planning of the cessation programs.
Methods
This is a descriptive and cross-sectional study with evaluation of 216 
patients enrolled in the Tobacco Control Program within the public 
sector from May to August 2012. These patients were from the four 
Health Units of Cuiabá/MT-Brazil (Júlio Müller University Hospital, 
Coxipó Polyclinic, Planalto Polyclinic and Campo Velho Health 
Center), which provided treatment through the Brazilian Health 
Care System (SUS) to patients with tobacco dependence. 
All the smokers enrolled in the program during the period of 
study were invited to participate in this study. Participants used the 
same treatment protocol: Nicotine Replacement Therapy (NRT) + 
bupropion + cognitive behavioral therapy (CBT). After receiving the 
medication from the assistant physician all smokers went through 
the initial assessment (T0) with the main researcher (psychologist) 
who oriented them about the proposed treatment and scheduled the 
TCC. After clarification of the objective proposed and the signing 
of the Free and Informed Consent the following tools for data col-
lection were applied: 
1. Socio-demographic profile questionnaire: Prepared by 
researchers for this study and divided into two parts. Part 
I – Identification and socio-demographic data: gender, 
age, school level, marital status, income and occupation/
profession. Part II – Smoking status: how long he/she has 
been smoking, number of cigarettes/day, age at which the 
person started to smoke and smoking burden (cutoff point 
20  years-package). In the results of smoking status, the pa-
rameters used to categorize the variables were the median, 
except in the smoking burden where it was considered a 
higher dependence for being above 2014.
2. Fagerström Test (FTND): Self-administered questionnaire 
which contains 6 items and that shows the individual’s degree 
of dependence in relation to nicotine in the levels: very low 
(0 to 2 points), low (3 to 4 points), moderate (5 points), high 
(6 to 7 points) and very high (8 to 10 points)15. For statistical 
analysis of the results, the smokers with results ≥ 5 were 
classified as highly dependent and the value below 5 as mildly 
dependent3,14. 
3. Beck Anxiety Inventory (BAI): A scale that was developed in 
order to measure anxiety both in psychiatric patients and in 
the general population and consists of a list with 21 common 
symptoms of anxiety, where the patient indicates how he had 
been feeling in the previous week, up to the current day. For 
this study the results were classified in minimal/mild and 
moderate/severe16.
4. Beck Depression Inventory (BDI): This inventory also 
consists of 21 groups of statements, where the patient in-
dicates how he/she had been feeling the preceding week. 
The evaluation of the BDI classifies the participants within 
four levels: minimal, which suggests absence of depression, 
mild, moderate and severe depression. Here the results were 
classified in minimal/mild and moderate/severe as well17.
Later, the data were entered in an Epidata software version 3.1, 
and analyzed by the Statistical Package for the Social Sciences (SPSS) 
version 17.0. Next, a bivariate analysis was carried out, using the 
crude prevalence ratio with its respective intervals of confidence of 
95% (CI 95%) and level of significance less than 5% (p < 0.05). The 
variables with levels of significance inferior to 20% (p < 0.20), by 
the chi-square test, were listed to be tested in the Multiple Poisson 
Regression Model with strong variance (RPa), remaining in the final 
model the variables which presented a p value lower than 5% (p < 
0.05). Poisson model was chosen for being the alternative used in 
the epidemiological literature which estimates the relative risk in a 
cross-sectional study, using the prevalence ratio18. 
The dependent variable (outcome) corresponded to the FTND ≥ 5. 
The independent variables were based on three hierarchical levels for 
determining the variables related to the outcomes which are proximal 
(anxiety and depression, smoking history and cigarettes per day). 
Variables representing status of smoking as age of onset, attempts 
to quit smoking, length of smoking and gender can be considered 
intermediate. The more distal factors refer to other socio-demographic 
data such as income, occupation, age and years at school.
This research, with Certificate of Submission for Ethical Review 
(CAAE nº 0106612.6.0000.5541), was approved on May 9th 2012 by 
the Research Ethics Committee (CEP) of Júlio Müller University 
Hospital under CEP’s Approval nº 19548.
Results
Table 1 shows the association between the level of nicotine depen-
dence and the socio-demographic factors. It is possible to observe 
that high nicotine dependence (Fagerström ≥ 5) is associated with the 
male gender (RP 1.15; CI 95% 1.03-1.28). There was no association 
with the other factors studied: age group (p = 0.615), income (p = 
0.892), education (p = 0.976) and occupation (p = 0.923). 
The association between the level of nicotine dependence and the 
smoking status is in table 2. High nicotine dependence is associated 
with the highest number of cigarettes smoked per day (RP 1.33; CI 
95% 1.19-1.48) and tobacco intake ≥ 20 (RP 1.35; CI 95% 1.11-1.64). 
There was no association between high dependence and length of 
smoking habit (p = 0.315), age at which he/she started smoking (p = 
0.829) or number of attempts to quit smoking (p = 0.564). 
The results of the instruments used to evaluate the level of anxiety 
(BAI) or depression (BDI) are in table 3. It is worth noting that high 
nicotine dependence is associated with the highest level of depres-
sion (RP 1.15; CI 95% 1.04-1.28), unlike the anxiety level that was 
not statistically significant (p = 0.619). 
In table 4 the final model of the multivariate analysis of the 
Crude Poisson Regression (RPa) is presented. The following variables 
remained associated with the high nicotine dependence (Fagerström 
≥ 5): male gender (RPa 1.12; CI 95% 1.01-1.24), higher number of 
cigarettes smoked per day (RPa 1.28; CI 95% 1.15-1.43), and higher 
level of depression (RPa 1.12; CI 95% 1.01-1.23).
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Table 1. Results of the bivariate analysis of the association between nicotine dependence and socio-demographic factors, Cuiabá-MT, Brazil
Variables Category Fagerström RPb CI 95% p
≥ 5 Until 4
n % n %
Gender Male 69 92.00 6 8.00 1.15 [1.03; 1.28] 0.023
Female 113 80.14 28 19.86 1.00 - -
Age 20-39 years 41 82.00 9 18.00 1.06 [0.84; 1.33] 0.615
40-59 years 117 86.67 18 13.33 1.12 [0.92; 1.37] 0.262F
60 years or more 24 77.42 7 22.58 1.00 - -
Income > Median (2.000) 78 83.87 15 16.13 0.99 [0.88; 1.12] 0.892
≤ Median (2.000) 104 84.55 19 15.45 1.00 - -
Years of school > 8 128 84.21 24 15.79 1.00 [0.88; 1.13] 0.976
≤ 8 54 84.38 10 15.62 1.00 - -
Occupation Don’t work 68 83.95 13 16.05 0.99 [0.88; 1.12] 0.923
Work 114 84.44 21 15.56 1.00 - -
RPb: Crude Prevalence Ratio; CI 95%: confidence interval of 95%; p: Level of significance considering the distribution of the chi-square test.
Table 2. Results of the bivariate analysis of the association between nicotine dependence and smoking status, Cuiabá-MT
Variables Categories Fagerström RPb CI 95% p
≥ 5 Until 4
n % N %
Duration of 
smoking habit
≤ 20 years 44 80.00 11 20.00 0.93 [0.81; 1.08] 0.315
> 20 years 138 85.71 23 14.29 1.00 - -
Age of beginning 
tobacco use 
> Median (16) 82 83.67 16 16.33 0.99 [0.88; 1.11] 0.829
≤ Median (16) 100 84.75 18 15.25 1.00 - -
Cigarettes per 
day
> Median (20) 92 97.87 2 2.13 1.33 [1.19; 1.48] < 0.001
≤ Median (20) 90 73.77 32 26.23 1.00 - -
Tobacco intake ≥ 20 146 90.12 16 9.88 1.35 [1.11; 1.64] < 0.001
< 20 36 66.67 18 33.33 1.00 - -
Attempts to quit 
smoking 
None 35 81.40 8 18.60 0.96 [0.82; 1.12] 0.564
Some 147 84.97 26 15.03 1.00 - -
RPb: Crude Prevalence Ratio; CI 95%: confidence interval of 95%; p: level of significance considering the distribution of the chi-square test.
Table 3. Results of the bivariate analysis of the association between nicotine dependence and the instruments of psychological evaluation Cuiabá-MT, Brazil
Variables Category Fagerström RPb CI 95% p
≥ 5 Until 4
N % n %
BAI Moderate/
severe
72 82.76 15 17.24 0.97 [0.86; 1.09] 0.619
Minimal/mild 110 85.27 19 14.73 1.00
BDI Moderate/
severe
62 92.54 5 7.46 1.15 [1.04; 1.28] 0.025
Minimal/mild 120 80.54 29 19.46 1.00 - -
RPb: Crude Prevalence ratio; CI 95%: confidence interval of 95%; p: level of significance considering the distribution of the chi-square test. 
Table 4. Adjusted Prevalence Ratio Poisson Crude Regression RPa, of the variables associated with Fagerström ≥ 5 (in 216 patients, with their respective 
interval of confidence (IC) of 95% and the p value of the variables selected by the backward method, Cuiabá-MT, Brazil
Variables Categories RPa CI 95% P Value
Sex Male 1.12 1.01 – 1.24 0.029
Female 1.00
Cigarettes per day > Median (20) 1.28 1.15 – 1.43 < 0.001
≤ Median (20) 1.00
BDI Moderate/severe 1.12 1,01 – 1.23 0.031
Minimal/mild 1.00
RPa: prevalence ratio adjusted in the poisson regression model with selection of variables; CI: confidence interval. 
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Discussion 
The results of this study demonstrate the influence of the relationship 
between smoking and depression. They show the association between 
the level of nicotine dependence, measured by the Fagerström test, 
and higher level of depression recorded by validated instrument to 
define the levels of depressive symptoms (BDI). These data are con-
sistent with literature, where high level of addition by the Fagerström 
test was associated with severe depressive symptoms19,20.
It is known that the highest level of nicotine dependence is a 
determining factor for the success of smoking cessation and that 
several characteristics of the smokers are interrelated19. In this 
study, regarding the socio-demographic data, the male gender was 
the variable associated with high nicotine dependence, both for the 
bivariate analysis and the final regression model used. This result is 
consistent with some researches which show that being male was 
one of the variables considered as predictor of higher dependence, 
with men presenting higher dependence than women21. However, 
other studies show different results which report that the gender has 
not been associated with the level of dependence evaluated by the 
Fagerström test22. 
A higher number of cigarettes smoked per day and high tobacco 
intake were also variables which were associated with high nicotine 
dependence. This result was expected, since there are  numerous 
 studies which show that the higher the daily consumption of 
cigarettes and tobacco intake, the higher is the nicotine dependence 
level19,21. The explanation for that is: people who smoke more than 20 
cigarettes a day are usually nicotine-dependent and subject to strong 
withdrawal symptoms23. The nicotine-dependent smoker has a strong 
desire or sense of compulsion to consume the substance, difficulty in 
controlling the behavior of consuming the substance in terms of its 
initiation, ending or levels of consumption, a state of physiological 
withdrawal when the use of the substance has ceased or been reduced, 
which characterizes the withdrawal syndrome24.
In relation to the levels of depression and anxiety and the associa-
tion with higher levels of nicotine dependence the results found here 
show that only depression can be associated, which confirms many 
of the literature reports19. On the other hand, these data differ from 
researches that find no association between nicotine dependence and 
depression in the male gender25, as well as non-association between 
severity of smoking and depression among male or female smokers22.
The depressive symptoms are heterogeneous and include sadness, 
anhedonia (inability to experience pleasure), problems of concentra-
tion, changes in appetite or weight, sleep disorder, excessive guilt 
and others24. The depressive symptomatology is higher in smokers 
with high level of addition, as well as those who have a history of 
higher cumulative consumption of cigarettes. Other reports show 
that tobacco is associated with psychiatric morbidity and moderate 
to severe depression19,26 and that nicotine seems to be a form of self-
medication, taking into account that it can change the mood and 
alleviate the depressive symptoms. In relation to this last hypothesis 
(self-medication), the authors report that smoking can fight the symp-
toms of discouragement and sadness which are typical of depression, 
however this fact leads the smoker to consume a higher quantity of 
cigarettes per day and that it can potentially increase nicotine depen-
dence12. Moreover, smoking and depression can influence each other. 
Some smokers try to find relief from negative and undesirable feelings 
in the cigarettes and, thus, tobacco for these people can be a positive 
reinforcer27. The relationship between smoking and depression has 
not been investigated yet to determine the real meaning of cause-effect 
between tobacco and depression, as well as the adequate treatment9,28.
In this study anxiety has not been associated with the nicotine 
dependence level differing from the result found in other researches19. 
In relation to the association of nicotine with anxiety there is con-
troversy, because some authors emphatically state that anxiety does 
not show a direct relationship with smoking. Others are categorical 
in emphasizing the relationship between them, pointing that it 
depends on the diagnosis of the type of anxiety disorder29. Anxiety 
can be defined as an emotional state with psychological and physi-
ological components, which is part of the normal spectrum of human 
 experiences and encourages performance. It can become pathological 
when it is disproportionate to the situation which triggers it, or when 
there is no specific object to relate to30. Yet, leaving this academic 
discussion, the role played by anxiety in the smokers in smoking 
cessation process must be remembered at the time of service, aiming 
to assist them to overcome their symptoms.
With regard to limitations of this study, one can highlight those 
related to the instruments of data collection. The Fagerström test, one 
of the most used questionnaires to investigate nicotine dependence, 
has its own limitations, since it can assess only physical but not 
psychological dependence5. The Beck Anxiety Inventory  evaluates 
the presence of anxiety symptoms in general. However, it does not 
identify the presence of symptomatology of specific anxiety disorders, 
such as panic disorder and social phobia, among others. Even so, these 
minor limitations do not invalidate the results found in this study, 
because the data analyzed are important to support future planning 
actions to improve the assistance to smokers with depressive symp-
toms and high nicotine dependence. In conclusion, the high nicotine 
dependence is associated with male smokers, higher quantity of ciga-
rettes smoked per day and the moderate/severe level of depression. 
It is suggested that instruments assessing levels of depression and 
anxiety are included within the smoking cessation programs, with the 
adoption of individual or group psychological interventions, giving 
special attention to smokers with depressive symptoms. 
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